Journey Medical (DERM) executive compensation, 2026 proxy

Claude Maraoui, President and Chief Executive Officer, was paid $1.7M in 2025, down 36% from $2.6M the year before.

Filed
April 30, 2026
Annual meeting
June 24, 2026
Pay year
2025
Named executives
3
CEO total pay
$1.7M-36% vs prior year
CEO pay in equity
43%$715,646 in awards
CEO target bonus
75% of salaryReduced from 100% previously
CEO stock awards
$310,938
CEO option awards
$404,708
CEO bonus earned
81% of targetBased on 2025 performance
Alloush bonus earned
94% of targetBased on 2025 performance
Benesch bonus earned
90% of targetBased on 2025 performance

How Maraoui was paid

$1.7M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary35%Stock awards19%Option awards24%Non-equity incentive21%All other compensation1%

Named executive officers

ExecutiveTotal
Claude MaraouiPresident and Chief Executive Officer$1,665,876
Ramsey AlloushChief Operating Officer, Corporate Secretary and General Counsel$1,194,192
Joseph BeneschChief Financial Officer$823,673

What changed and why

  • $1.7M$1,665,876 was CEO total compensation in 2025, down from $2,597,684 in 2024.
  • 75%75% was the CEO’s annual milestone bonus opportunity, reduced from 100% previously.
  • 81%81% of target was the CEO’s earned annual bonus for 2025.
  • 2025 bonus goals included gross profit, net revenue, EBITDA, Emrosi revenue and gross-to-net.
  • Change-in-control agreements provide certain executives with target bonuses, benefit continuation and equity vesting.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.